收藏切换
Research progress on the role and intervention strategies of NRP1 in colorectal cancer
收藏切换
PDF
Xing-yu HUANG1, Yuan-yuan ZHAI1, Liu YANG1, 2, Pei ZHANG1, *, Feng-guo XU1, *
Acta Pharmaceutica Sinica | 2022, 57(8) : 2262 - 2268
Less
收藏切换
Acta Pharmaceutica Sinica | 2022, 57(8): 2262-2268
Reviews
Research progress on the role and intervention strategies of NRP1 in colorectal cancer
Full
Xing-yu HUANG1, Yuan-yuan ZHAI1, Liu YANG1, 2, Pei ZHANG1, *, Feng-guo XU1, *
Affiliations
  • 1. Key Laboratory of Drug Quality Control and Pharmacovigilance (Ministry of Education), China Pharmaceutical University, Nanjing 210009, China
  • 2. Jiangsu Cancer Hospital, Nanjing 210009, China
Published: 2022-08-12 doi: 10.16438/j.0513-4870.2022-0313
Outline
收藏切换

Colorectal cancer (CRC) is one of the most common malignant tumors in the world, and its incidence and mortality are among the top three of all malignant tumors. In recent years, CRC is becoming more common in younger patients. Currently, surgery is the main or first treatment of early stage CRC, however, up to 50% patients have recurrence and metastasis post-surgery. While chemotherapy and radiotherapy are often used as adjuvant treatment after surgery or as main treatment options for late stage CRC, they usually induce severe adverse effects. Safe and effective treatments for CRC are still lacking. Therefore, it is essential to discover new therapies for CRC. Neuropilin 1 (NRP1), as a transmembrane glycoprotein, is reported to highly express in CRC, and its overexpression is demonstrated to be closely related to the occurrence and development of CRC. NRP1 is involved in angiogenesis, tumor growth, autophagy, and lipid metabolism, which is expected to be a potential new target for the treatment of CRC. This paper reviews the role of NRP1 in CRC, including its molecular structure, expression in CRC, as well as its connection with autophagy and metabolism. The regulatory factors of NRP1 in CRC were introduced, including vascular endothelial growth factor (VEGF), semaphorin 3A (SEMA3A), transforming growth factor-β (TGF-β), etc. The potential intervention strategies of CRC targeting NRP1 were summarized in order to provide reference for the diagnosis and prevention of CRC.

colorectal cancer  /  neuropilin 1  /  cancer targeting  /  inhibitor  /  intervention strategy
Xing-yu HUANG, Yuan-yuan ZHAI, Liu YANG, Pei ZHANG, Feng-guo XU. Research progress on the role and intervention strategies of NRP1 in colorectal cancer[J]. Acta Pharmaceutica Sinica, 2022 , 57 (8) : 2262 -2268 . DOI: 10.16438/j.0513-4870.2022-0313
Year 2022 volume 57 Issue 8
PDF
159
61
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2022-0313
  • Receive Date:2022-03-11
  • Online Date:2025-12-23
  • Published:2022-08-12
Article Data
Affiliations
History
  • Received:2022-03-11
  • Revised:2022-04-05
Funding
Affiliations
    1. Key Laboratory of Drug Quality Control and Pharmacovigilance (Ministry of Education), China Pharmaceutical University, Nanjing 210009, China
    2. Jiangsu Cancer Hospital, Nanjing 210009, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2022-0313
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT